Abstract

Endometrial cancer (EC) is the most common malignant tumor in post-menopausal women, and the lung is one of the organs to which endometrial adenocarcinoma metastasizes. Chemotherapy is helpful for various malignancies, but not all are successful. A 71-year-old-Japanese-woman was diagnosed with metastatic lung cancer stage IV of primary endometrial adenocarcinoma. She received chemotherapy and hormone therapy after a total hysterectomy and pelvic lymphadenectomy. Subsequently, she visited this clinic for a second opinion as the metastatic lung cancer had repeated remissions and recurrences. Here, the authors report a case in which complete remission of metastatic lung cancer was achieved by using a product containing low molecular weight fucoidan extract (LMF) and Canavalia gladiata extract (CG) (LMF-CG) in combination with Medroxyprogesterone acetate (MPA) hormone therapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call